Stryker price target raised to $321 from $314 at Barclays

Barclays raised the firm’s price target on Stryker to $321 from $314 and keeps an Overweight rating on the shares. The magnitude of Stryker’s Q1 beat made it hard for management to do anything but temper expectations for the rest of the year, the analyst tells investors in a research note. The firm remains bullish on the company’s "durable" growth profile, but says Stryker will likely need to deliver further upside and upward guidance revisions to drive the stock significantly higher in the near-term.